Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunnel Halldén

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 28, 2011
Adenoviral gene expression and replication in human tumor explant modelsGunnel Halldén
Oncolytic Virotherapy|September 1, 2016
Oncolytic adenovirus-mediated therapy for prostate cancerKatrina Sweeney, Gunnel Halldén
Expert Opinion on Therapeutic Targets|August 14, 2012
Oncolytic virotherapy with modified adenoviruses and novel therapeutic targetsGunnel Halldén, Giuseppe Portella
Current Opinion in Molecular Therapeutics|August 3, 2010
Adenovirus-based therapy for prostate cancerMaria Ekblad, Gunnel Halldén
Cancer Letters|July 9, 2018
Advances in oncolytic adenovirus therapy for pancreatic cancerCallum Baird Nattress, Gunnel Halldén
Frontiers in Molecular Biosciences|July 11, 2022
Targeting Triple Negative Breast Cancer With Oncolytic AdenovirusesGabriela Green-Tripp, Callum Nattress, Gunnel Halldén
Oncotarget|February 13, 2016
The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11Constantia Pantelidou, Gioia Cherubini, Nick R Lemoine, et al.
The Journal of Biological Chemistry|October 27, 2004
Peptide YY and neuropeptide Y induce villin expression, reduce adhesion, and enhance migration in small intestinal cells through the regulation of CD63, matrix metalloproteinase-3, and Cdc42 activityMike Lee, Margono Hadi, Gunnel Halldén, et al.
Methods in Molecular Medicine|December 6, 2003
Replication-selective oncolytic adenovirusesGunnel Halldén, Stephen H Thorne, Jingping Yang, et al.
Cancers|June 16, 2018
Designer Oncolytic Adenovirus: Coming of AgeAlexander T Baker, Carmen Aguirre-Hernández, Gunnel Halldén, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|September 28, 2011
Adenoviral gene expression and replication in human tumor explant modelsGunnel Halldén
Oncolytic Virotherapy|September 1, 2016
Oncolytic adenovirus-mediated therapy for prostate cancerKatrina Sweeney, Gunnel Halldén
Expert Opinion on Therapeutic Targets|August 14, 2012
Oncolytic virotherapy with modified adenoviruses and novel therapeutic targetsGunnel Halldén, Giuseppe Portella
Current Opinion in Molecular Therapeutics|August 3, 2010
Adenovirus-based therapy for prostate cancerMaria Ekblad, Gunnel Halldén
Cancer Letters|July 9, 2018
Advances in oncolytic adenovirus therapy for pancreatic cancerCallum Baird Nattress, Gunnel Halldén
Frontiers in Molecular Biosciences|July 11, 2022
Targeting Triple Negative Breast Cancer With Oncolytic AdenovirusesGabriela Green-Tripp, Callum Nattress, Gunnel Halldén
Oncotarget|February 13, 2016
The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11Constantia Pantelidou, Gioia Cherubini, Nick R Lemoine, et al.
The Journal of Biological Chemistry|October 27, 2004
Peptide YY and neuropeptide Y induce villin expression, reduce adhesion, and enhance migration in small intestinal cells through the regulation of CD63, matrix metalloproteinase-3, and Cdc42 activityMike Lee, Margono Hadi, Gunnel Halldén, et al.
Methods in Molecular Medicine|December 6, 2003
Replication-selective oncolytic adenovirusesGunnel Halldén, Stephen H Thorne, Jingping Yang, et al.
Cancers|June 16, 2018
Designer Oncolytic Adenovirus: Coming of AgeAlexander T Baker, Carmen Aguirre-Hernández, Gunnel Halldén, et al.
Pageof 3